J.P. Morgan, TD Cowen, SVB Securities, and Guggenheim Securities are acting as joint book-running managers for the proposed offering. UBS Investment Bank is acting as lead manager.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RVMD:
- Revolution Medicines Announces Commencement of Public Offering of Common Stock
- Revolution Medicines Blasts Up after Earnings
- Revolution Medicines price target raised to $38 from $32 at Needham
- Revolution Medicines price target raised to $35 from $30 at Oppenheimer
- Revolution Medicines upgraded to Overweight from Neutral at JPMorgan
